Kristen L. Veraldi

Kristen L. Veraldi

Auto-generated profile, based on publicly available information

Kristen L. Veraldi

Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1997 in Nucleic Acids Research
Verified
Journal Article
Closed access
GEG Edwalds-Gilbert
G Edwalds-Gilbert
KVK L Veraldi
K L Veraldi
CMC Milcarek
C Milcarek
Many genes have been described and characterized which result in alternative polyadenylation site use at the 3'-end of their mRNAs based on the cellular environment. In this survey and summary article 95 genes are discussed in which alternative polyadenylation is a consequence of tandem arrays of poly(A) signals within a single 3'-untranslated region. An additional 31 genes are described in which polyadenylation at a promoter-proximal site competes with a splicing reaction to influence expression of multiple mRNAs. Some have a composite internal/terminal exon which can be differentially processed. Others contain alternative 3'-terminal exons, the first of which can be skipped in some cells. In some cases the mRNAs formed from these three classes of genes are differentially processed from the primary transcript during the cell cycle or in a tissue-specific or developmentally specific pattern. Immunoglobulin heavy chain genes have composite exons; regulated production of two different Ig mRNAs has been shown to involve B cell stage-specific changes in trans -acting factors involved in formation of the active polyadenylation complex. Changes in the activity of some of these same factors occur during viral infection and take-over of the cellular machinery, suggesting the potential applicability of at least some aspects of the Ig model. The differential expression of a number of genes that undergo alternative poly(A) site choice or polyadenylation/splicing competition could be regulated at the level of amounts and activities of either generic or tissue-specific polyadenylation factors and/or splicing factors.

1 February 2001 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
KVKristen L. Veraldi
Kristen L. Veraldi
GAGeorge K. Arhin
George K. Arhin
KMKathleen Martincic
Kathleen Martincic
LCLing-Hsiu Chung-Ganster
Ling-Hsiu Chung-Ganster
JWJeffrey Wilusz
Jeffrey Wilusz
Christine MilcarekChristine Milcarek
Christine Milcarek
Previous studies on the regulation of polyadenylation of the immunoglobulin (Ig) heavy-chain pre-mRNA argued fortrans-acting modifiers of the cleavage-polyadenylation reaction operating differentially during B-cell developmental stages. Using four complementary approaches, we demonstrate that a change in the level of hnRNP F is an important determinant in the regulated use of alternative polyadenylation sites between memory and plasma stage B cells. First, by Western analyses of cellular proteins, the ratio of hnRNP F to H or H′ was found to be higher in memory B cells than in plasma cells. In memory B cells the activity of CstF-64 binding to pre-mRNA, but not its amount, was reduced. Second, examination of the complexes formed on input pre-mRNA in nuclear extracts revealed large assemblages containing hnRNP H, H′, and F but deficient in CstF-64 in memory B-cell extracts but not in plasma cells. Formation of these large complexes is dependent on the region downstream of the AAUAAA in pre-mRNA, suggesting that CstF-64 and the hnRNPs compete for a similar region. Third, using a recombinant protein we showed that hnRNP F could bind to the region downstream of a poly(A) site, block CstF-64 association with RNA, and inhibit the cleavage reaction. Fourth, overexpression of recombinant hnRNP F in plasma cells resulted in a decrease in the endogenous Ig heavy-chain mRNA secretory form-to-membrane ratio. These results demonstrate that mammalian hnRNP F can act as a negative regulator in the pre-mRNA cleavage reaction and that increased expression of F in memory B cells contributes to the suppression of the Ig heavy-chain secretory poly(A) site.

30 May 2012 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
YYYukie Yamaguchi
Yukie Yamaguchi
TTTakahisa Takihara
Takahisa Takihara
RCRoger A. Chambers
Roger A. Chambers
KVKristen L. Veraldi
Kristen L. Veraldi
ALAdriana T. Larregina
Adriana T. Larregina
CFCarol A. Feghali-Bostwick
Carol A. Feghali-Bostwick
A naturally occurring peptide from endostatin can inhibit fibrosis in lung and skin, even when it is already established.

26 August 2011 in Arthritis & Rheumatism
Verified
Journal Article
Open access
PDF file
MBMonique Brissett
Monique Brissett
KVKristen L. Veraldi
Kristen L. Veraldi
JPJoseph M. Pilewski
Joseph M. Pilewski
TMThomas A. Medsger
Thomas A. Medsger
CFCarol A. Feghali‐Bostwick
Carol A. Feghali‐Bostwick
Objective: To determine the role of insulin‐like growth factor binding protein 3 (IGFBP‐3) in mediating the effects of transforming growth factor β (TGFβ) on tenascin‐C (TN‐C) production and to assess the levels of TN‐C in vivo in patients with systemic sclerosis (SSc)–associated pulmonary fibrosis.Methods: Human primary lung fibroblasts were stimulated with TGFβ or IGFBP‐3 in the presence or absence of specific small interfering RNAs and chemical inhibitors of the signaling cascade. TN‐C levels in lung tissue specimens obtained from patients with SSc‐associated pulmonary fibrosis were assessed using immunohistochemical analysis and were compared with the levels in specimens obtained from normal donors. TN‐C levels were quantified in sera from normal donors and patients with SSc with or without pulmonary fibrosis, using an enzyme‐linked immunosorbent assay.Results: IGFBP‐3 mediated the induction of TN‐C by TGFβ. Direct induction of TN‐C by IGFBP‐3 occurred in a p38 MAP kinase–dependent manner. TN‐C levels were abundant in lung tissues from patients with SSc and were localized to subepithelial layers of the distal airways. No TN‐C was detectable around the proximal airways. Patients with SSc‐associated pulmonary fibrosis had significantly higher levels of circulating TN‐C compared with SSc patients without pulmonary fibrosis. Longitudinal samples obtained from patients with SSc before and after the onset of pulmonary fibrosis showed increased levels of TN‐C after the onset of pulmonary fibrosis.Conclusion: IGFBP‐3, which is overexpressed in fibrotic lungs, induces production of TN‐C by subepithelial fibroblasts. The increased lung tissue levels of TN‐C parallel the levels detected in the sera of SSc patients with pulmonary fibrosis, suggesting that TN‐C may be a useful biomarker for SSc‐related pulmonary fibrosis.

1 March 2007 in Chest
Verified
Journal Article
Closed access
JPJoshua Portnoy
Joshua Portnoy
KVKristen L. Veraldi
Kristen L. Veraldi
MSMarvin I. Schwarz
Marvin I. Schwarz
CCCarlyne D. Cool
Carlyne D. Cool
DCDouglas Curran-Everett
Douglas Curran-Everett
KBKevin K. Brown
Kevin K. Brown

1 October 1995 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PAPratima Adhikari
Pratima Adhikari
SKShane D. Kirby
Shane D. Kirby
ANAndrew J. Nowalk
Andrew J. Nowalk
KVKristen L. Veraldi
Kristen L. Veraldi
ASAnthony B. Schryvers
Anthony B. Schryvers
TMTimothy A. Mietzner
Timothy A. Mietzner
Bacterial iron transport is critical for growth of pathogens in the host environment, where iron is limited as a form of nonspecific immunity. For Gram-negative bacteria such as Haemophilus influenzae, iron first must be transported across the outer membrane and into the periplasmic space, then from the periplasm to the cytosol. H. influenzae express a periplasmic iron-binding protein encoded by the hitA gene. This gene is organized as the first of a three-gene operon purported to encode a classic high affinity iron acquisition system that includes hitA, a cytoplasmic permease (hitB), and a nucleotide binding protein (hitC). In this study we describe the cloning, overexpression, and purification of the H. influenzae hitA gene product. The function of this protein is unambiguously assigned by demonstrating its ability to compete for iron bound to the chemical iron chelator 2,2'-dipyridyl, both in vitro and within the periplasmic space of a siderophore-deficient strain of Escherichia coli. Finally, the importance of a functional hitABC operon for iron acquisition is demonstrated by complementation of this siderophore-deficient E. coli to growth on dipyridyl-containing medium. These studies represent a detailed genetic, biochemical, and physiologic description of an active transport system that has evolved to efficiently transport iron and consequently is widely distributed among Gram-negative pathogenic bacteria.